Cargando…

Sublobar resection versus lobectomy in the treatment of synchronous multiple primary lung cancer

OBJECTIVE: Although synchronous multiple primary lung cancers (sMPLCs) are common in clinical practice, the choice of surgical modalities for the main lesion is still at the stage of exploration. This study is designed to analyze the prognosis of sMPLCs and single primary lung cancers with similar t...

Descripción completa

Detalles Bibliográficos
Autores principales: Niu, Niu, Zhou, Liang, Zhao, Junjie, Ma, Xingjie, Yang, Fan, Qi, Weibo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10124016/
https://www.ncbi.nlm.nih.gov/pubmed/37088839
http://dx.doi.org/10.1186/s12957-023-02996-w
_version_ 1785029765783093248
author Niu, Niu
Zhou, Liang
Zhao, Junjie
Ma, Xingjie
Yang, Fan
Qi, Weibo
author_facet Niu, Niu
Zhou, Liang
Zhao, Junjie
Ma, Xingjie
Yang, Fan
Qi, Weibo
author_sort Niu, Niu
collection PubMed
description OBJECTIVE: Although synchronous multiple primary lung cancers (sMPLCs) are common in clinical practice, the choice of surgical modalities for the main lesion is still at the stage of exploration. This study is designed to analyze the prognosis of sMPLCs and single primary lung cancers with similar tumor stages and to explore whether sublobar resection has a similar prognosis as lobectomy for sMPLCs. METHODS: One-hundred forty-one cases of sMPLCs were selected, including the following: 65 cases underwent lobectomy for main lesions, and 76 cases underwent sublobar resection for main lesions. One thousand one hundred forty-four cases of single primary lung cancer were matched at 1:1 by propensity score matching. Then, the patients with sMPLCs were divided into a lobectomy group and a sublobar group according to the first tumor stage. Ninety-eight cases of patients with sMPLCs were matched. The short-term perioperative effect, 5-year disease-free survival (DFS) rate, and 5-year overall survival (OS) rate between the two groups were compared. RESULTS: There was no significant difference in OS between sMPLCs and single primary lung cancer after lobectomy (77.1% vs. 77.2%, P = 0.157) and sublobar resection (98.7% vs. 90.7%, P = 0.309). There was no significant difference in OS (86.7% vs. 83.9%, P = 0.482) or DFS (67.6 vs. 87.7%, P = 0.324) between the lobectomy group and sublobar group with sMPLCs. The sublobar resection group obtained a lower incidence of postoperative complications (40.8% vs. 16.3%, P = 0.007) and shorter postoperative hospital stay (11.22 vs. 9.27, P = 0.049). CONCLUSION: The prognosis of patients with sMPLCs generally depends on the main tumor state, which has no statistical difference regardless of sublobar resection or lobectomy, and the perioperative period of sublobar resection is safer than that of lobectomy.
format Online
Article
Text
id pubmed-10124016
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-101240162023-04-25 Sublobar resection versus lobectomy in the treatment of synchronous multiple primary lung cancer Niu, Niu Zhou, Liang Zhao, Junjie Ma, Xingjie Yang, Fan Qi, Weibo World J Surg Oncol Research OBJECTIVE: Although synchronous multiple primary lung cancers (sMPLCs) are common in clinical practice, the choice of surgical modalities for the main lesion is still at the stage of exploration. This study is designed to analyze the prognosis of sMPLCs and single primary lung cancers with similar tumor stages and to explore whether sublobar resection has a similar prognosis as lobectomy for sMPLCs. METHODS: One-hundred forty-one cases of sMPLCs were selected, including the following: 65 cases underwent lobectomy for main lesions, and 76 cases underwent sublobar resection for main lesions. One thousand one hundred forty-four cases of single primary lung cancer were matched at 1:1 by propensity score matching. Then, the patients with sMPLCs were divided into a lobectomy group and a sublobar group according to the first tumor stage. Ninety-eight cases of patients with sMPLCs were matched. The short-term perioperative effect, 5-year disease-free survival (DFS) rate, and 5-year overall survival (OS) rate between the two groups were compared. RESULTS: There was no significant difference in OS between sMPLCs and single primary lung cancer after lobectomy (77.1% vs. 77.2%, P = 0.157) and sublobar resection (98.7% vs. 90.7%, P = 0.309). There was no significant difference in OS (86.7% vs. 83.9%, P = 0.482) or DFS (67.6 vs. 87.7%, P = 0.324) between the lobectomy group and sublobar group with sMPLCs. The sublobar resection group obtained a lower incidence of postoperative complications (40.8% vs. 16.3%, P = 0.007) and shorter postoperative hospital stay (11.22 vs. 9.27, P = 0.049). CONCLUSION: The prognosis of patients with sMPLCs generally depends on the main tumor state, which has no statistical difference regardless of sublobar resection or lobectomy, and the perioperative period of sublobar resection is safer than that of lobectomy. BioMed Central 2023-04-24 /pmc/articles/PMC10124016/ /pubmed/37088839 http://dx.doi.org/10.1186/s12957-023-02996-w Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Niu, Niu
Zhou, Liang
Zhao, Junjie
Ma, Xingjie
Yang, Fan
Qi, Weibo
Sublobar resection versus lobectomy in the treatment of synchronous multiple primary lung cancer
title Sublobar resection versus lobectomy in the treatment of synchronous multiple primary lung cancer
title_full Sublobar resection versus lobectomy in the treatment of synchronous multiple primary lung cancer
title_fullStr Sublobar resection versus lobectomy in the treatment of synchronous multiple primary lung cancer
title_full_unstemmed Sublobar resection versus lobectomy in the treatment of synchronous multiple primary lung cancer
title_short Sublobar resection versus lobectomy in the treatment of synchronous multiple primary lung cancer
title_sort sublobar resection versus lobectomy in the treatment of synchronous multiple primary lung cancer
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10124016/
https://www.ncbi.nlm.nih.gov/pubmed/37088839
http://dx.doi.org/10.1186/s12957-023-02996-w
work_keys_str_mv AT niuniu sublobarresectionversuslobectomyinthetreatmentofsynchronousmultipleprimarylungcancer
AT zhouliang sublobarresectionversuslobectomyinthetreatmentofsynchronousmultipleprimarylungcancer
AT zhaojunjie sublobarresectionversuslobectomyinthetreatmentofsynchronousmultipleprimarylungcancer
AT maxingjie sublobarresectionversuslobectomyinthetreatmentofsynchronousmultipleprimarylungcancer
AT yangfan sublobarresectionversuslobectomyinthetreatmentofsynchronousmultipleprimarylungcancer
AT qiweibo sublobarresectionversuslobectomyinthetreatmentofsynchronousmultipleprimarylungcancer